Cargando…
The evolving treatment paradigm of lung cancer in China
Autores principales: | Xie, Wei, Liu, Shuanghuan, Li, Guanqiao, Xu, Huiyan, Zhou, Liyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069462/ https://www.ncbi.nlm.nih.gov/pubmed/35530151 http://dx.doi.org/10.1016/j.apsb.2022.01.010 |
Ejemplares similares
-
Drug discovery in China: A snapshot of recent progress
por: Hu, Hongxi, et al.
Publicado: (2022) -
Analysis of new drug registration and review in China in 2021
por: Hu, Hongxi, et al.
Publicado: (2022) -
Evolving treatment paradigms in esophageal cancer
por: Turgeman, Ilit, et al.
Publicado: (2021) -
Shifting the paradigm in Evolve and Resequence studies: From analysis of single nucleotide polymorphisms to selected haplotype blocks
por: Barghi, Neda, et al.
Publicado: (2019) -
Evolving folding
por: Wells, William A.
Publicado: (2007)